AVDL logo

Avadel Pharmaceuticals plc (AVDL) Operating Profit

Annual Operating Profit:

-$42.40M+$95.45M(+69.24%)
December 31, 2024

Summary

  • As of today (October 8, 2025), AVDL annual operating income is -$42.40 million, with the most recent change of +$95.45 million (+69.24%) on December 31, 2024.
  • During the last 3 years, AVDL annual operating profit has risen by +$43.20 million (+50.47%).
  • AVDL annual operating profit is now -141.68% below its all-time high of $101.72 million, reached on December 31, 2015.

Performance

AVDL Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

Quarterly Operating Profit:

$8.88M+$11.88M(+396.03%)
June 1, 2025

Summary

  • As of today (October 8, 2025), AVDL quarterly operating income is $8.88 million, with the most recent change of +$11.88 million (+396.03%) on June 1, 2025.
  • Over the past year, AVDL quarterly operating profit has increased by +$21.63 million (+169.73%).
  • AVDL quarterly operating profit is now -70.68% below its all-time high of $30.30 million, reached on September 30, 2015.

Performance

AVDL Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

TTM Operating Profit:

$2.26M+$21.63M(+111.66%)
June 1, 2025

Summary

  • As of today (October 8, 2025), AVDL TTM operating income is $2.26 million, with the most recent change of +$21.63 million (+111.66%) on June 1, 2025.
  • Over the past year, AVDL TTM operating profit has increased by +$101.05 million (+102.29%).
  • AVDL TTM operating profit is now -97.78% below its all-time high of $101.92 million, reached on December 31, 2015.

Performance

AVDL TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

AVDL Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+69.2%+169.7%+102.3%
3Y3 Years+50.5%+133.7%+102.2%
5Y5 Years-152.0%+295.3%+107.7%

AVDL Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+69.2%at high+117.9%at high+101.6%
5Y5-Year-152.0%+69.2%at high+117.9%at high+101.6%
All-TimeAll-Time-141.7%+69.2%-70.7%+117.9%-97.8%+101.6%

AVDL Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$8.88M(+396.0%)
$2.26M(+111.7%)
Mar 2025
-
-$3.00M(+9.0%)
-$19.37M(+54.3%)
Dec 2024
-$42.40M(+69.2%)
-$3.30M(-908.3%)
-$42.40M(+33.8%)
Sep 2024
-
-$327.00K(+97.4%)
-$64.00M(+35.2%)
Jun 2024
-
-$12.74M(+51.1%)
-$98.79M(+27.1%)
Mar 2024
-
-$26.04M(-4.6%)
-$135.59M(+1.6%)
Dec 2023
-$137.85M(-44.8%)
-$24.90M(+29.1%)
-$137.85M(-1.2%)
Sep 2023
-
-$35.11M(+29.1%)
-$136.16M(-15.3%)
Jun 2023
-
-$49.54M(-75.1%)
-$118.08M(-24.4%)
Mar 2023
-
-$28.30M(-21.9%)
-$94.89M(+0.3%)
Dec 2022
-$95.22M(-11.2%)
-$23.22M(-36.3%)
-$95.22M(-0.1%)
Sep 2022
-
-$17.03M(+35.4%)
-$95.14M(+8.3%)
Jun 2022
-
-$26.34M(+8.0%)
-$103.77M(-4.4%)
Mar 2022
-
-$28.63M(-23.7%)
-$99.36M(-16.1%)
Dec 2021
-$85.60M(-133.5%)
-$23.14M(+9.8%)
-$85.60M(-11.6%)
Sep 2021
-
-$25.66M(-17.0%)
-$76.72M(-17.9%)
Jun 2021
-
-$21.94M(-47.6%)
-$65.05M(-36.5%)
Mar 2021
-
-$14.86M(-4.2%)
-$47.66M(-30.0%)
Dec 2020
-$36.66M(-117.9%)
-$14.26M(-1.9%)
-$36.66M(-24.5%)
Sep 2020
-
-$13.99M(-207.6%)
-$29.45M(-72.1%)
Jun 2020
-
-$4.55M(-17.8%)
-$17.11M(-7.7%)
Mar 2020
-
-$3.86M(+45.2%)
-$15.88M(+5.6%)
Dec 2019
-$16.83M(+72.2%)
-$7.04M(-325.9%)
-$16.83M(+30.1%)
Sep 2019
-
-$1.65M(+50.2%)
-$24.06M(+44.8%)
Jun 2019
-
-$3.32M(+30.9%)
-$43.55M(+22.0%)
Mar 2019
-
-$4.80M(+66.4%)
-$55.85M(+7.8%)
Dec 2018
-$60.55M(-199.3%)
-$14.28M(+32.5%)
-$60.55M(-16.6%)
Sep 2018
-
-$21.14M(-35.3%)
-$51.92M(-243.6%)
Jun 2018
-
-$15.62M(-64.4%)
-$15.11M(-167.2%)
Mar 2018
-
-$9.50M(-68.4%)
$22.48M(-63.2%)
Dec 2017
$61.01M(+37.7%)
-$5.64M(-136.0%)
$61.01M(-23.8%)
Sep 2017
-
$15.66M(-28.7%)
$80.01M(+15.9%)
Jun 2017
-
$21.96M(-24.3%)
$69.01M(+16.2%)
Mar 2017
-
$29.02M(+117.2%)
$59.40M(+34.0%)
Dec 2016
$44.32M(-56.4%)
$13.36M(+186.8%)
$44.32M(-22.9%)
Sep 2016
-
$4.66M(-62.3%)
$57.48M(-30.8%)
Jun 2016
-
$12.36M(-11.4%)
$83.12M(-17.2%)
Mar 2016
-
$13.95M(-47.4%)
$100.39M(-1.5%)
Dec 2015
$101.72M(+406.8%)
$26.52M(-12.5%)
$101.92M(+56.6%)
Sep 2015
-
$30.30M(+2.2%)
$65.09M(+151.9%)
Jun 2015
-
$29.63M(+91.6%)
$25.84M(+344.1%)
Mar 2015
-
$15.47M(+250.1%)
-$10.59M(+67.6%)
Dec 2014
-$33.15M(-29.7%)
-$10.31M(-15.1%)
-$32.65M(-10.6%)
Sep 2014
-
-$8.96M(-31.8%)
-$29.52M(-12.1%)
Jun 2014
-
-$6.79M(-3.0%)
-$26.32M(-4.1%)
Mar 2014
-
-$6.59M(+8.2%)
-$25.28M(+1.1%)
Dec 2013
-$25.57M(-18.5%)
-$7.18M(-24.7%)
-$25.57M(-10.0%)
Sep 2013
-
-$5.76M(-0.1%)
-$23.23M(-1.3%)
Jun 2013
-
-$5.75M(+16.3%)
-$22.93M(+1.7%)
Mar 2013
-
-$6.88M(-41.8%)
-$23.33M(-8.1%)
Dec 2012
-$21.58M(-125.2%)
-$4.85M(+11.1%)
-$21.58M(-13.5%)
Sep 2012
-
-$5.46M(+11.3%)
-$19.01M(-54.4%)
Jun 2012
-
-$6.15M(-20.0%)
-$12.31M(-25.4%)
Mar 2012
-
-$5.13M(-125.1%)
-$9.82M(-2.5%)
Dec 2011
-$9.58M(+2.6%)
-$2.28M(-283.6%)
-$9.58M(-82.2%)
Sep 2011
-
$1.24M(+133.9%)
-$5.26M(+45.4%)
Jun 2011
-
-$3.65M(+25.3%)
-$9.63M(+10.0%)
Mar 2011
-
-$4.89M(-339.2%)
-$10.70M(-8.8%)
Dec 2010
-$9.84M
$2.04M(+165.4%)
-$9.84M(+44.8%)
DateAnnualQuarterlyTTM
Sep 2010
-
-$3.13M(+33.9%)
-$17.82M(+1.2%)
Jun 2010
-
-$4.73M(-17.3%)
-$18.03M(-6.6%)
Mar 2010
-
-$4.03M(+32.1%)
-$16.92M(-44.0%)
Dec 2009
-$11.75M(+10.8%)
-$5.94M(-77.9%)
-$11.75M(-213.2%)
Sep 2009
-
-$3.34M(+7.7%)
-$3.75M(+25.4%)
Jun 2009
-
-$3.62M(-417.6%)
-$5.03M(+29.6%)
Mar 2009
-
$1.14M(-44.8%)
-$7.15M(+45.8%)
Dec 2008
-$13.18M(+67.7%)
$2.06M(+144.7%)
-$13.18M(+43.4%)
Sep 2008
-
-$4.62M(+19.5%)
-$23.30M(+16.6%)
Jun 2008
-
-$5.73M(-17.1%)
-$27.95M(+22.8%)
Mar 2008
-
-$4.89M(+39.3%)
-$36.23M(+11.3%)
Dec 2007
-$40.85M(-5.2%)
-$8.06M(+13.0%)
-$40.85M(+1.0%)
Sep 2007
-
-$9.26M(+33.9%)
-$41.26M(+3.2%)
Jun 2007
-
-$14.01M(-47.1%)
-$42.64M(-11.6%)
Mar 2007
-
-$9.52M(-12.4%)
-$38.21M(+1.6%)
Dec 2006
-$38.84M(+4.7%)
-$8.47M(+20.5%)
-$38.84M(+6.3%)
Sep 2006
-
-$10.64M(-11.0%)
-$41.46M(+3.6%)
Jun 2006
-
-$9.59M(+5.5%)
-$43.00M(+0.8%)
Mar 2006
-
-$10.14M(+8.5%)
-$43.33M(-6.3%)
Dec 2005
-$40.77M(-561.4%)
-$11.09M(+8.9%)
-$40.77M(-65.3%)
Sep 2005
-
-$12.18M(-22.8%)
-$24.66M(-138.0%)
Jun 2005
-
-$9.92M(-30.8%)
-$10.36M(-309.6%)
Mar 2005
-
-$7.58M(-251.0%)
-$2.53M(-128.6%)
Dec 2004
$8.84M(+288.0%)
$5.02M(+137.1%)
$8.84M(+169.7%)
Sep 2004
-
$2.12M(+201.5%)
$3.28M(+662.9%)
Jun 2004
-
-$2.08M(-155.1%)
-$582.00K(-144.5%)
Mar 2004
-
$3.78M(+800.7%)
-$238.00K(+96.3%)
Dec 2003
-$4.70M(-2007.2%)
-$540.00K(+69.0%)
-$6.44M(+31.3%)
Sep 2003
-
-$1.74M(0.0%)
-$9.37M(-73.3%)
Jun 2003
-
-$1.74M(+28.0%)
-$5.41M(-506.4%)
Mar 2003
-
-$2.42M(+30.4%)
$1.33M(-84.0%)
Dec 2002
-$223.00K(+92.9%)
-$3.47M(-256.3%)
$8.31M(+8046.1%)
Sep 2002
-
$2.22M(-55.5%)
$102.00K(-79.8%)
Jun 2002
-
$5.00M(+9.6%)
$504.00K(+124.4%)
Mar 2002
-
$4.56M(+139.0%)
-$2.06M(+34.6%)
Dec 2001
-$3.15M(+80.4%)
-$11.68M(-545.0%)
-$3.15M(+79.8%)
Sep 2001
-
$2.63M(+7.9%)
-$15.58M(-2.5%)
Jun 2001
-
$2.43M(-29.8%)
-$15.21M(-2.8%)
Mar 2001
-
$3.47M(+114.4%)
-$14.80M(+9.1%)
Dec 2000
-$16.11M(-130.1%)
-$24.11M(-903.6%)
-$16.28M(-407.6%)
Sep 2000
-
$3.00M(+5.6%)
-$3.21M(+29.0%)
Jun 2000
-
$2.84M(+43.4%)
-$4.52M(+28.4%)
Mar 2000
-
$1.98M(+118.0%)
-$6.32M(+9.7%)
Dec 1999
-$7.00M(+24.7%)
-$11.03M(-753.6%)
-$7.00M(+41.0%)
Sep 1999
-
$1.69M(+61.4%)
-$11.86M(-0.1%)
Jun 1999
-
$1.05M(-19.5%)
-$11.85M(-16.2%)
Mar 1999
-
$1.30M(+108.2%)
-$10.19M(+28.7%)
Dec 1998
-$9.29M(-3.2%)
-$15.89M(-1034.8%)
-$14.29M(-18.1%)
Sep 1998
-
$1.70M(-37.0%)
-$12.10M(+4.0%)
Jun 1998
-
$2.70M(+196.4%)
-$12.60M(+10.0%)
Mar 1998
-
-$2.80M(+79.6%)
-$14.00M(-53.8%)
Dec 1997
-$9.00M(0.0%)
-$13.70M(-1241.7%)
-$9.10M(-12.3%)
Sep 1997
-
$1.20M(-7.7%)
-$8.10M(+5.8%)
Jun 1997
-
$1.30M(-38.1%)
-$8.60M(+4.4%)
Mar 1997
-
$2.10M(+116.5%)
-$9.00M(+26.2%)
Dec 1996
-$9.00M
-$12.70M(-1914.3%)
-$12.20M(-2540.0%)
Sep 1996
-
$700.00K(-22.2%)
$500.00K(+350.0%)
Jun 1996
-
$900.00K(+181.8%)
-$200.00K(+81.8%)
Mar 1996
-
-$1.10M
-$1.10M

FAQ

  • What is Avadel Pharmaceuticals plc annual operating income?
  • What is the all-time high annual operating profit for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual operating profit year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly operating income?
  • What is the all-time high quarterly operating profit for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly operating profit year-on-year change?
  • What is Avadel Pharmaceuticals plc TTM operating income?
  • What is the all-time high TTM operating profit for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc TTM operating profit year-on-year change?

What is Avadel Pharmaceuticals plc annual operating income?

The current annual operating profit of AVDL is -$42.40M

What is the all-time high annual operating profit for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual operating income is $101.72M

What is Avadel Pharmaceuticals plc annual operating profit year-on-year change?

Over the past year, AVDL annual operating income has changed by +$95.45M (+69.24%)

What is Avadel Pharmaceuticals plc quarterly operating income?

The current quarterly operating profit of AVDL is $8.88M

What is the all-time high quarterly operating profit for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly operating income is $30.30M

What is Avadel Pharmaceuticals plc quarterly operating profit year-on-year change?

Over the past year, AVDL quarterly operating income has changed by +$21.63M (+169.73%)

What is Avadel Pharmaceuticals plc TTM operating income?

The current TTM operating profit of AVDL is $2.26M

What is the all-time high TTM operating profit for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high TTM operating income is $101.92M

What is Avadel Pharmaceuticals plc TTM operating profit year-on-year change?

Over the past year, AVDL TTM operating income has changed by +$101.05M (+102.29%)
On this page